
Rubix LS
About Rubix LS
Rubix LS is a culturally competent contract research organization focused on advancing medical treatments for diseases and cancers affecting underserved populations. Founded in 2016 and originally known as Rubix Strategies, the organization operates at the intersection of life and science, conducting patient-centric research particularly for conditions that have lacked sufficient access to innovative treatments and cures. Their primary mission is to eradicate rare diseases through transformative research and development, coupled with breakthroughs in engineering. Operating as a digital health research and development company, Rubix LS concentrates on addressing the growing disparities in health outcomes among minority groups. They tackle disparities in disease diagnosis and therapeutic outcomes, particularly focusing on underrepresented patients suffering from rare diseases, infectious diseases, and oncology-related diseases. Rubix LS is committed to running diverse clinical trials, enhancing real-world evidence for prevalent conditions, and ensuring that patients can utilize their data effectively.
Services
Therapeutic areas
Experience & capabilities
Browse companies by location
Similar CRO companies in United States
Integrated Expertise for Complex Clinical Development Modern clinical trials—especially those with complex, innovative designs—require a coordinated, cross-functional approach to…
Ace Therapeutics is a preclinical contract research provider. We are dedicated to providing one-stop services for our clients. Our business has extended into various fields…
ACENTH
CROAdvanced Clinical is a clinical development and strategic resourcing organization committed to providing a better clinical experience across the drug development journey. Our goal…